CompletedNot Applicable

Delirium in Covid-19: Germany-wide Covid-19 Intensive Register

Germany2,398 participantsStarted 2021-01-01

Plain-language summary

The global pandemic caused by the SARS-CoV-2 virus is confronting the German health system with a novel pathogen. This means that a timely evaluation of all available results is required. In the field of intensive care in particular, there are significant gaps in knowledge, particularly with regard to delirium. In this respect, this study also serves directly to investigate the pathways of delirium outcome in COVID-19 patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: All patients with SARS-CoV-2 positive Covid-19 disease * Age≥18 years * Proven by positive PCR tests from nasal/ throat swabs as well as samples from the deep respiratory tract. * Period 01.01.2020 to 21.02.2022 Exclusion Criteria: * NONE

What they're measuring

Incidence of delirium

Timeframe: 01.01.2020 - 21.02.2022

Trial details

NCT IDNCT04775017

SponsorCharite University, Berlin, Germany

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-02-21

View on ClinicalTrials.gov More Intensive Care Unit Delirium trials